CELL BIOLOGY INTERNATIONAL

Scope & Guideline

Shaping the Future of Cell Biology and Medicine

Introduction

Immerse yourself in the scholarly insights of CELL BIOLOGY INTERNATIONAL with our comprehensive guidelines detailing its aims and scope. This page is your resource for understanding the journal's thematic priorities. Stay abreast of trending topics currently drawing significant attention and explore declining topics for a full picture of evolving interests. Our selection of highly cited topics and recent high-impact papers is curated within these guidelines to enhance your research impact.
LanguageEnglish
ISSN1065-6995
PublisherWILEY
Support Open AccessNo
CountryUnited States
TypeJournal
Convergefrom 1993 to 2024
AbbreviationCELL BIOL INT / Cell Biol. Int.
Frequency12 issues/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
Address111 RIVER ST, HOBOKEN 07030-5774, NJ

Aims and Scopes

CELL BIOLOGY INTERNATIONAL focuses on the intricate mechanisms of cellular processes and their implications in health and disease. The journal publishes cutting-edge research that encompasses various aspects of cell biology, including cellular signaling, molecular interactions, and the role of stem cells in regenerative medicine.
  1. Cellular Mechanisms in Cancer Biology:
    The journal emphasizes studies that elucidate the molecular and cellular mechanisms underlying cancer progression, including cell signaling pathways, tumor microenvironment interactions, and the role of exosomes in cancer metastasis.
  2. Stem Cell Research and Applications:
    A significant focus is placed on stem cell biology, including differentiation, regenerative potential, and therapeutic applications for various diseases, highlighting innovative methodologies in stem cell research.
  3. Cellular Responses to Stress and Injury:
    Research exploring how cells respond to various forms of stress, including oxidative stress, hypoxia, and nutrient deprivation, along with studies on cell death mechanisms such as apoptosis and ferroptosis.
  4. Cellular Interactions and Communication:
    The journal covers investigations into how cells communicate and interact within their environments, including studies on extracellular vesicles, cytokine signaling, and immune cell interactions.
  5. Innovative Therapeutic Strategies:
    CELL BIOLOGY INTERNATIONAL also aims to present novel therapeutic approaches targeting cellular processes, including gene editing, nanomedicine, and the use of natural compounds in treatment regimens.
The journal has shown a clear trend towards emerging themes that reflect the current advancements in cell biology. These trending scopes highlight areas of increasing interest and relevance in contemporary research.
  1. Ferroptosis and Other Cell Death Mechanisms:
    There is a growing focus on ferroptosis as a regulated form of cell death, particularly in cancer and neurodegenerative diseases, indicating an interest in understanding how this process can be manipulated for therapeutic purposes.
  2. MicroRNAs and Epigenetic Regulation:
    Research on microRNAs and their role in gene regulation is on the rise, particularly concerning their implications in cancer progression and treatment resistance, showcasing the importance of non-coding RNAs in cellular processes.
  3. Immunotherapy and Cancer Immunology:
    The journal is increasingly publishing studies related to immunotherapy, including the role of immune cells in cancer, checkpoint inhibitors, and the development of novel immunotherapeutic strategies.
  4. Extracellular Vesicles in Disease Modulation:
    Investigations into the roles of extracellular vesicles in intercellular communication and their potential as biomarkers or therapeutic targets are trending, reflecting their significance in various pathological contexts.
  5. Stem Cell-Derived Therapies and Regenerative Medicine:
    The emphasis on stem cell applications in regenerative medicine is growing, with a focus on novel methodologies for enhancing stem cell therapies and their implications in treating degenerative diseases.

Declining or Waning

While CELL BIOLOGY INTERNATIONAL continues to explore a diverse range of topics, certain themes appear to be losing prominence in recent publications. These declining scopes indicate a shift in research trends and interests within the field.
  1. Basic Mechanistic Studies:
    There is a noticeable decline in purely basic mechanistic studies that do not translate into clinical relevance or therapeutic applications, as the journal increasingly favors research with direct implications for disease treatment.
  2. Non-cancer Related Cellular Biology:
    Research focusing on general cellular biology unrelated to cancer or regenerative medicine appears to be waning. The journal's emphasis is shifting towards studies that explicitly relate to cancer biology and regenerative therapies.
  3. Historical Reviews and Perspectives:
    Traditional review articles that do not provide new insights or data are becoming less common, as the journal prioritizes original research and innovative reviews that contribute significantly to current scientific discourse.

Similar Journals

CELL PROLIFERATION

Unlocking the Mysteries of Cell Growth and Division
Publisher: WILEYISSN: 0960-7722Frequency: 12 issues/year

CELL PROLIFERATION, published by Wiley, is a leading open-access journal that has been at the forefront of research since its inception in 1968. With an impact factor that solidifies its position in the Q1 category of both Cell Biology and Medicine (Miscellaneous), this journal serves as a premier platform for disseminating groundbreaking studies in the field of cellular and molecular biology. The journal is renowned for its rigorous peer-review process and comprehensive coverage of topics related to cell growth, division, and differentiation, making it an invaluable resource for researchers, professionals, and students alike. With its notable Scopus ranking of #30 in Biochemistry, Genetics, and Molecular Biology: Cell Biology, and a robust open access model since 2019, CELL PROLIFERATION ensures that cutting-edge research is accessible to a global audience, fostering collaboration and innovation across the scientific community. Located in the United Kingdom, the journal remains committed to enhancing the understanding of cellular processes, thereby influencing developments in medicine and biotechnology.

TRENDS IN CELL BIOLOGY

Uncovering the Latest Trends in Cell Science
Publisher: CELL PRESSISSN: 0962-8924Frequency: 12 issues/year

TRENDS IN CELL BIOLOGY, published by CELL PRESS, is a premier journal in the field of cell biology, recognized for its high-impact contributions since its inception in 1991. As a distinguished member of the Q1 quartile within its category, the journal holds an impressive Scopus ranking of #8 out of 285, placing it in the 97th percentile of the field, which underscores its reputation for excellence. The journal serves as an essential resource for researchers, professionals, and students who are engaged with groundbreaking advancements in biochemistry, genetics, and molecular biology. Although it is not open access, it provides critical insights into the latest trends, reviews, and advancements in cell biology, making it a crucial tool for anyone committed to understanding the complexities of cellular systems. With a focus on innovative and transformative research, TRENDS IN CELL BIOLOGY continues to shape the discourse in cell biology and enhance the scientific community's knowledge.

BIOCELL

Elevating Scientific Dialogue in Cell Biology
Publisher: TECH SCIENCE PRESSISSN: 0327-9545Frequency: 12 issues/year

BIOCELL is a distinguished peer-reviewed journal dedicated to the field of Cell Biology, published by TECH SCIENCE PRESS. Since its inception in 1995, the journal has been at the forefront of disseminating innovative research, with converged publication years extending from 1995 to 2013 and from 2015 to 2024. Although it currently holds a Q4 ranking in the Cell Biology category according to the 2023 category quartiles, BIOCELL aims to foster advancements by providing a platform for researchers, professionals, and students to share their findings in biochemistry, genetics, and molecular biology. The journal is available in both print (ISSN: 0327-9545) and digital formats (E-ISSN: 1667-5746) and seeks to attract contributions that enhance scholarly dialogue and understandings of cellular mechanisms and innovations. With a commitment to quality research and critical discourse, BIOCELL plays an important role in nurturing the scientific community within Argentina and beyond, offering vital insights that contribute to the advancement of the life sciences.

Cell Death & Disease

Illuminating pathways from cell death to disease impact.
Publisher: SPRINGERNATUREISSN: 2041-4889Frequency: 1 issue/year

Cell Death & Disease, published by SpringerNature, is a premier open-access journal dedicated to disseminating high-quality research on the mechanisms and implications of cell death, disease pathology, and therapeutic responses. Since its inception in 2010, the journal has quickly established itself within the top tier of academic publishing, achieving a notable impact factor and earning Q1 rankings in several critical categories including Cancer Research, Cell Biology, Cellular and Molecular Neuroscience, Immunology, and Medicine (miscellaneous). With its commitment to open access, Cell Death & Disease ensures that groundbreaking research is available to a global audience, fostering collaboration and advancing knowledge across disciplines. Residing at the forefront of crucial scientific discourse, this journal not only attracts submissions from leading researchers but also significantly influences the fields of molecular biology, immunology, and neurology. By bridging the gap between basic science and clinical applications, it provides vital insights for professionals, academicians, and students alike.

JOURNAL OF CELLULAR PHYSIOLOGY

Elevating Understanding of Cellular Mechanisms
Publisher: WILEYISSN: 0021-9541Frequency: 12 issues/year

JOURNAL OF CELLULAR PHYSIOLOGY, published by Wiley, is a leading peer-reviewed journal that has been at the forefront of cellular research since its inception in 1945. With its prestigious Q1 and Q2 rankings in the fields of Clinical Biochemistry and Cell Biology, this journal is highly regarded within the scientific community, reflecting its significant impact factor and rigorous peer-review process. Addressing the intricacies of cell function and physiology, it serves as a crucial resource for researchers, professionals, and students dedicated to advancing knowledge in the life sciences. The journal publishes cutting-edge research articles, integral reviews, and significant findings that bridge basic biology and clinical applications, ensuring access to high-quality scholarly content that informs current practices and future research directions. Although not open access, the journal maintains a rich archive of studies, making it an essential reference point for those invested in the health and biological sciences.

Cell Stress

Driving Innovation in Cancer Research and Beyond
Publisher: SHARED SCIENCE PUBLISHERS OGISSN: Frequency: 12 issues/year

Cell Stress is a prestigious, peer-reviewed open access journal dedicated to advancing research in the fields of biochemistry, genetics, molecular biology, cancer research, and physiology. Published by SHARED SCIENCE PUBLISHERS OG in Austria, this journal has rapidly established itself since its inception in 2017, achieving Q1 status in multiple categories, indicative of its high impact and quality. With an impressive Scopus ranking—holding a top percentile position in its respective fields—Cell Stress aims to foster interdisciplinary collaboration and disseminate cutting-edge findings that enhance our understanding of cellular stress mechanisms and their implications in health and disease. The journal's commitment to open access since its launch ensures that critical research is accessible to a global audience, thereby facilitating the exchange of knowledge among researchers, professionals, and students alike. Address your submissions or inquiries to AM BLUMENHAG 25-4, Graz 8010, Austria, and contribute to this dynamic platform that is shaping the future of molecular medicine.

JOURNAL OF CELLULAR BIOCHEMISTRY

Shaping the Future of Biochemical and Cellular Research
Publisher: WILEYISSN: 0730-2312Frequency: 12 issues/year

Journal of Cellular Biochemistry is a premier academic journal dedicated to advancing the field of biochemistry and cellular biology. Published by Wiley, this influential journal has a significant impact factor that underscores its relevance and authority within the scientific community. With its ISSN 0730-2312 and E-ISSN 1097-4644, the journal has been on the frontier of research since its inception in 1982, and is expected to continue publishing cutting-edge studies through 2024. As evidenced by its ranking in the 2023 Scopus Quartiles, it holds a rank of Q2 in Biochemistry and Q3 in both Cell and Molecular Biology, placing it among the top tiers of scientific journals in these disciplines. The Journal of Cellular Biochemistry serves as a vital resource for researchers, professionals, and students alike, providing a platform for the dissemination of innovative ideas and findings that shape our understanding of cellular processes and biochemical pathways. Though it does not currently offer Open Access options, its robust peer-review process ensures that each publication meets the highest academic standards, thus solidifying its esteemed position in the landscape of biochemical research.

Cell Death Discovery

Advancing insights into the mysteries of cell death.
Publisher: SPRINGERNATUREISSN: Frequency: 1 issue/year

Cell Death Discovery, published by Springer Nature, is a distinguished open-access journal dedicated to advancing the field of cell death research. Since its inception in 2015, the journal has rapidly established itself as a premier platform for high-quality research, currently holding a remarkable position in the Q1 quartiles across multiple categories, including Cancer Research, Cell Biology, Cellular and Molecular Neuroscience, and Immunology. With an impact factor reflecting its significant contribution to the scientific community, Cell Death Discovery invites submissions that explore the molecular mechanisms of cell death and its implications across various biomedical fields. The journal's open-access model ensures that groundbreaking research is accessible to a global audience, facilitating collaboration and dissemination among researchers, professionals, and students alike. Located in the UK, at CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND, the journal continues to support innovative scholarship and foster a deeper understanding of the processes behind cell viability, development, and disease.

Molecular Cell

Advancing the Frontiers of Cell and Molecular Science.
Publisher: CELL PRESSISSN: 1097-2765Frequency: 24 issues/year

Molecular Cell, published by Cell Press, is a leading journal in the fields of cell biology and molecular biology. Established in 1997, this prestigious journal boasts a significant impact within the scientific community, evidenced by its impressive 2023 Scopus rankings, placing it in the top 2% of its field (Rank #10/410 in Molecular Biology, Rank #12/285 in Cell Biology). With a focus on cutting-edge research that bridges the gap between molecular genetics and cellular function, Molecular Cell serves as an essential platform for the dissemination of vital findings and innovative methodologies. Although it follows a traditional publishing model without Open Access options, its rigorous peer-review process and high standards ensure that articles published within these pages are of the utmost quality, making it an invaluable resource for researchers, professionals, and students alike seeking to stay at the forefront of scientific discovery. The journal's address is 50 Hampshire St, Floor 5, Cambridge, MA 02139, United States, reinforcing its commitment to fostering scientific excellence and collaboration.

FASEB BioAdvances

Unlocking the Secrets of Life Sciences
Publisher: WILEYISSN: Frequency: 12 issues/year

FASEB BioAdvances, published by WILEY, is an esteemed open-access journal dedicated to advancing the fields of biochemistry, molecular biology, and physiology. Since its inception in 2019, the journal has rapidly established a significant presence within the academic community, boasting an impressive impact factor reflective of its Q2 and Q3 standings across various categories, including Biochemistry, Genetics and Molecular Biology, Cancer Research, Molecular Medicine, and Physiology. The journal aims to disseminate high-quality research and innovative findings to enhance the understanding of biological processes, making it a vital resource for researchers, professionals, and students alike. With its commitment to open access, FASEB BioAdvances ensures that groundbreaking research is available to a global audience, facilitating collaboration and exploration in these rapidly evolving scientific domains.